MyLife Diabetes Care today announced its next steps as an independent diabetes care technology company. Burgdorf, Switzerland-based MyLife says it has now become the legal manufacturer for MyLife products, as of today, June 1, 2026. It plans to introduce products under the new legal manufacturer to the market in a step-by-step process beginning July 1, […]
Drug-Device Combinations
Ascensia launches new insulin pen needles
Ascensia Diabetes Care, a PHC Holdings subsidiary, today announced the launch of its Contour Comfort pen needles. The Basel, Switzerland-based company said the launch further strengthens its Contour portfolio with a solution that improves the everyday injection experience. It marks the company’s entry into the pen needle category. Ascensia designed Contour Comfort pen needles to […]
Court overturns $60M verdict for Insulet in EOFlow trade secret battle
The U.S. Court of Appeals for the Federal Circuit in Washington, D.C., has sided with EOFlow in its patent spat with Insulet (Nasdaq:PODD). In its decision, the court overturned a verdict from 2024 that ordered EOFlow to pay nearly $60 million to Insulet. A jury found that EOFlow and several other defendants misappropriated Insulet’s trade secrets […]
MannKind wins FDA approval for inhaled insulin for children with type 1, type 2 diabetes
MannKind (Nasdaq:MNKD) announced today that it received FDA approval for its Afrezza inhaled insulin powder for children. FDA approval covers use in children and adolescents aged 6 and older with type 1 and type 2 diabetes. Afrezza (insulin human) inhalation powder is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler […]
Medtrum data highlights time in range with automated insulin delivery system
Medtrum said that a study of its automated insulin delivery (AID) technology demonstrated increased time in range for people with diabetes. In 20 adults with type 1 diabetes, investigators evaluated the performance of the Medtrum A8 TouchCare in AID mode over three months. Findings included more time in range (70-180 mg/dL), increasing from 59.08% to […]
ViCentra CEO explains how Kaleido can compete with ‘handbrake off,’ increased growth, scale
Since ViCentra closed an $85 million funding round in September 2025, the milestones have continued to stack up. The Dutch automated insulin delivery system developer added a a $13 million extension to that Series D round in January. CEO Tom Arnold outlined the company’s plans for the cash infusion last year, including scaling manufacturing. Today, […]
ViCentra triples manufacturing capacity ahead of Kaleido rollout through Phillips Medisize collab
ViCentra announced today that it began commercial-scale production of its Kaleido insulin pump technology at Phillips Medisize. The Dutch automated insulin delivery system developer said it began production of consumables, including infusion sets and insulin cartridges, with the Molex company — a leading global medical technology contract development and manufacturing organization (CDMO). The collaboration more […]
Abbott wins CE mark for dual glucose-ketone sensor
Abbott (NYSE:ABT) announced today that it received CE mark approval for its dual glucose-ketone sensing technology for people with diabetes. The company said its dual sensor marks a world first, continuously measuring glucose and ketone levels every minute. Branded as Libre Duo and Libre Duo 10 Day, the sensors provide real-time visibility into glucose levels […]
Insulet initiates another Omnipod 5 recall affecting 7 million devices including some Dash, Eros systems
Insulet (Nasdaq:PODD) today announced a voluntary medical device correction for specific lots of its Omnipod 5, Dash and Eros pods. The company identified a manufacturing issue through ongoing product monitoring that could result in insulin under-delivery with the affected current-generation Omnipod 5, previous-generation Omnipod Dash or the prior Omnipod Insulin Management System (Eros). Insulet said […]
MiniMed launches MiniMed Go smart multiple daily injection system in US
MiniMed (Nasdaq:MMED) announced today that it began the U.S. launch of MiniMed Go, a connected smart multiple daily injection (MDI) system. The smart MDI system integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within a mobile app to deliver real-time, personalized insights and actionable guidance. The platform targets people […]
